CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease.
Tsagkaraki E, Nicoloro SM, DeSouza T, Solivan-Rivera J, Desai A, Lifshitz LM, Shen Y, Kelly M, Guilherme A, Henriques F, Amrani N, Ibraheim R, Rodriguez TC, Luk K, Maitland S, Friedline RH, Tauer L, Hu X, Kim JK, Wolfe SA, Sontheimer EJ, Corvera S, Czech MP.
Tsagkaraki E, et al. Among authors: ibraheim r.
Nat Commun. 2021 Nov 26;12(1):6931. doi: 10.1038/s41467-021-27190-y.
Nat Commun. 2021.
PMID: 34836963
Free PMC article.